USPTO serial 78144228
Serial No. 78144228
Reviewed by CopyMark Law Group
Reg. 3311631Status 710
- Filing date
- Status date
- Registration date
- Oct 16, 2007
- Examiner
- BRODY, DANIEL S
- Law office
- —
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 78144228?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Huddinge, SE
Huddinge, SE
Huddinge, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mainak H. Mehta
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP1020 Marsh Road, Suite 200Menlo Park, CA 94025UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemical reagents for scientific or research use, namely, assays for identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances, such as enzymes or receptors, assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor, and tissue culture growth media; chemical preparations for use in medical research, namely, reagents for the identification of compounds that bind and/modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances such as enzymes or receptors; assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or receptor; biochemicals for industrial purposes, namely, tissue culture growth media; chemical and biological substances for use in the manufacture of medicinal, pharmaceutical and veterinary products ] | SECTION 8 - CANCELLED | — |
| 005 | [ Pharmaceutical preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; pharmaceutical substances, namely, dermatological creams for the treatment of skin disorders; veterinary preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; veterinary substances, namely, dermatological creams for use in the treatment of skin disorders, medicinal preparations for the treatment of metabolic disorders such as such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; medicinal substances, namely, dermatological cream for the treatment of skin disorders; medical diagnostic reagents; diagnostic agents for veterinary use; clinical medical reagents, namely, reagents for clinical-chemical tests; diagnostic reagents for clinical or medical laboratory use; vaccines; transdermal drug patches sold with medication for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, stroke, peripheral vascular disease, thromboembolism, retenosis of catheterization or surgical repairs, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections ] | SECTION 8 - CANCELLED | — |
| 010 | [ Diagnostic kits for medical and veterinary purposes comprised of diagnostic apparatus for medical and veterinary purposes, namely, apparatus used in identifying compounds that bind and/or modulate one or more biologically active substances, and assays and reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity of biologically active substances, such as enzymes and receptors and to identify antibacterial compounds; diagnostic apparatus for medical and veterinary purposes, namely, apparatus used in identifying compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity of biologically active substances, such as receptors and enzymes, and to identify antibacterial compounds ] | SECTION 8 - CANCELLED | — |
| 014 | [ Jewelry; watches; clocks; and key rings made of precious metal ] | SECTION 8 - CANCELLED | — |
| 016 | Publications and printed matter, namely, magazines, brochures and literature pertaining to drug research; stationery; pens, pencils, notebook binders and business cards | SECTION 8 - CANCELLED | — |
| 025 | Clothing namely, t-shirts, jumpers, fleece sweaters, jackets, caps and socks, footwear, head wear; and waterproof clothing, namely, t-shirts, jumpers, fleece sweaters, jackets, caps and socks, footwear, head wear | SECTION 8 - CANCELLED | — |
| 042 | Pharmaceutical research services; scientific research project management; scientific and industrial research; medical laboratory services; medical research; veterinary laboratory services | SECTION 8 - CANCELLED | — |
| 044 | Pharmaceutical advice services and provision of medical information | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Karo Bio AB
- Other trademarks owned by Karo Bio AB
- Other trademarks owned by Karo Bio AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 014
- Other trademarks in Class 016
- Other trademarks in Class 025
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 18, 2018 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Oct 16, 2016 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Apr 22, 2014 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Apr 22, 2014 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Apr 22, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 8, 2014 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Apr 8, 2014 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 16, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 31, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 11, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 26, 2007 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jun 15, 2007 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jun 13, 2007 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jun 13, 2007 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Jun 13, 2007 | NEWR | 1(B) BASIS DELETED; NEW BASIS APPROVED | — |
| Jun 7, 2007 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Jun 5, 2007 | APET | ASSIGNED TO PETITION STAFF | — |
| May 22, 2007 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 22, 2007 | PDCB | PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED | — |
| May 22, 2007 | PAPER RECEIVED | — | |
| Jan 19, 2007 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 29, 2006 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 29, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 27, 2006 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 15, 2006 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 12, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 14, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 9, 2006 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 7, 2005 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 7, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 20, 2005 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 13, 2005 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 13, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 16, 2004 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 6, 2004 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 6, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 15, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 23, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 3, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 5, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 15, 2003 | EMRV | EMAIL RECEIVED | — |
| Dec 12, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2003 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2003 | CFIT | CASE FILE IN TICRS | — |
| May 16, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 27, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 26, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 14, 2002 | DOCK | ASSIGNED TO EXAMINER | — |